Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2026
Reporting Period: Single event date (February 26, 2026)
Business Context: The filing discloses the release of an updated investor presentation (Exhibit 99.1) intended for use in meetings with investors and analysts. The presentation is incorporated by reference but is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves solely as a disclosure of a non-financial event (the release of an investor presentation) and does not contain audited or unaudited financial statements.
Material Changes
No material changes to financial performance or operations are reported in this filing. The only material event is the dissemination of updated corporate information via an investor presentation.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to use the attached presentation in various meetings with investors and analysts.
Outlook: The filing notes that the presentation may be amended or updated at any time through future filings.
Risks and Contingencies: The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is not subject to the liabilities of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Investor Presentation) for specific operational updates, clinical trial data, or financial projections not detailed in the 8-K text.
- Verify the current status of the Class A common stock (Symbol: VTVT) on the Nasdaq Capital Market.
- Monitor future filings for any amendments or updates to the presentation referenced in this report.
- Confirm that no other material events were omitted from this specific 8-K filing.